AmpliPhi BioSciences Corp has placed $7 million of convertible preferred stock with a group of life science investors in order to finance the development of therapeutics for infectious diseases including bacterial infections. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
